Cargando…

High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids

New treatments are required for advanced prostate cancer; however, there are fewer preclinical models of prostate cancer than other common tumor types to test candidate therapeutics. One opportunity to increase the scope of preclinical studies is to grow tissue from patient-derived xenografts (PDXs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choo, Nicholas, Ramm, Susanne, Luu, Jennii, Winter, Jean M., Selth, Luke A., Dwyer, Amy R., Frydenberg, Mark, Grummet, Jeremy, Sandhu, Shahneen, Hickey, Theresa E., Tilley, Wayne D., Taylor, Renea A., Risbridger, Gail P., Lawrence, Mitchell G., Simpson, Kaylene J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458687/ https://www.ncbi.nlm.nih.gov/pubmed/34111999 http://dx.doi.org/10.1177/24725552211020668

Ejemplares similares

Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer
por: Alizadeh-Ghodsi, Mohammadreza, et al.
Publicado: (2022)

SAT-330 Preclinical Screen of Patient CRPC Tumors Shows Sensitivity to Bromodomain Inhibitors Includes AR-null and Neuroendocrine Disease
por: Risbridger, Gail, et al.
Publicado: (2019)

To target or not to target the enemy within localized prostate cancer
por: Risbridger, Gail, et al.
Publicado: (2013)

Using a Quantitative High-Throughput Screening Platform to Identify Molecular Targets and Compounds as Repurposing Candidates for Endometriosis
por: Churchill, Molly L., et al.
Publicado: (2023)

Obesity does not promote tumorigenesis of localized patient-derived prostate cancer xenografts
por: Lo, Jennifer C.Y., et al.
Publicado: (2016)

PDX: Moving Beyond Drug Screening to Versatile Models for Research Discovery
por: Risbridger, Gail P, et al.
Publicado: (2020)

Estrogen Receptor β Activation Impairs Prostatic Regeneration by Inducing Apoptosis in Murine and Human Stem/Progenitor Enriched Cell Populations
por: Hussain, Shirin, et al.
Publicado: (2012)

Radiation therapy attenuates lymphatic vessel repair by reducing VEGFR-3 signalling
por: Pillay, Vinochani, et al.
Publicado: (2023)

Methodology for the identification of small molecule inhibitors of the Fanconi Anaemia ubiquitin E3 ligase complex
por: Sharp, Michael F., et al.
Publicado: (2020)

Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target()()
por: Lee, Rachel S, et al.
Publicado: (2019)

Primary apocrine adenocarcinoma of scrotum suspected as urothelial carcinoma metastasis: A clinical and pathological dilemma
por: Huang, Sean, et al.
Publicado: (2015)

FGFR3 signaling and function in triple negative breast cancer
por: Chew, Nicole J., et al.
Publicado: (2020)

Erratum to: IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptor
por: Carter, Sarah L., et al.
Publicado: (2016)

IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptor
por: Carter, Sarah Louise, et al.
Publicado: (2016)

Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer
por: Lawrence, Mitchell G., et al.
Publicado: (2020)

Cell-Type-Specific High Throughput Toxicity Testing in Human Midbrain Organoids
por: Renner, Henrik, et al.
Publicado: (2021)

Chimeric Antigen Receptor T-Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer
por: Perera, Mahasha P.J., et al.
Publicado: (2022)

The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology
por: Risbridger, Gail P., et al.
Publicado: (2021)

Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors
por: Gillis, Joanna L., et al.
Publicado: (2013)

Metabolic profiling and in vitro assessment of anthelmintic fractions of Picria fel-terrae Lour.
por: Kumarasingha, Rasika, et al.
Publicado: (2016)

The pseudokinase NRBP1 activates Rac1/Cdc42 via P-Rex1 to drive oncogenic signalling in triple-negative breast cancer
por: Yang, Xue, et al.
Publicado: (2023)

Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies
por: Chan, Siu Chiu, et al.
Publicado: (2015)

Predictors of erectile dysfunction after transperineal template prostate biopsy
por: Tan, Jo-Lynn, et al.
Publicado: (2021)

Expression and localisation of c-kit and KITL in the adult human ovary
por: Tuck, Astrud R, et al.
Publicado: (2015)

Functional high-throughput screen identifies microRNAs that promote butyrate-induced death in colorectal cancer cells
por: Ali, Saira R., et al.
Publicado: (2022)

OCT1-target neural gene PFN2 promotes tumor growth in androgen receptor-negative prostate cancer
por: Obinata, Daisuke, et al.
Publicado: (2022)

Preclinical Evidence of the Efficacy of Lewis Y Car T Cells in Patient-Derived Models of Prostate Cancer
por: Risbridger, Gail Petuna, et al.
Publicado: (2021)

Age Related Differences in Responsiveness to Sildenafil and Tamsulosin are due to Myogenic Smooth Muscle Tone in the Human Prostate
por: Lee, Sophie N., et al.
Publicado: (2017)

Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer
por: Obinata, Daisuke, et al.
Publicado: (2020)

Circulating MicroRNAs as Biomarkers of Prostate Cancer: The State of Play
por: Sapre, Nikhil, et al.
Publicado: (2013)

Patient-Derived Tumor Organoid Rings for Histologic Characterization and High-Throughput Screening
por: Nguyen, Huyen Thi Lam, et al.
Publicado: (2020)

High-throughput drug screening of fine-needle aspiration-derived cancer organoids
por: Bergdorf, Kensey, et al.
Publicado: (2020)

Discovering cancer vulnerabilities using high-throughput micro-RNA screening
por: Nikolic, Iva, et al.
Publicado: (2017)

A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids
por: Renner, Henrik, et al.
Publicado: (2020)

SGTA: A New Player in the Molecular Co-Chaperone Game
por: Philp, Lisa K., et al.
Publicado: (2013)

Comprehensive high-throughput image analysis for therapeutic efficacy of architecturally complex heterotypic organoids
por: Bulin, Anne-Laure, et al.
Publicado: (2017)

A High-Throughput Organoid Microinjection Platform to Study Gastrointestinal Microbiota and Luminal Physiology
por: Williamson, Ian A., et al.
Publicado: (2018)

Immersion Bioprinting of Tumor Organoids in Multi-Well Plates for Increasing Chemotherapy Screening Throughput
por: Maloney, Erin, et al.
Publicado: (2020)

Microfluidic Platforms for High-Throughput Pancreatic Ductal Adenocarcinoma Organoid Culture and Drug Screening
por: Geyer, Marlene, et al.
Publicado: (2021)

Assay establishment and validation of a high-throughput organoid-based drug screening platform
por: Li, Xiaomeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3ba8o4h0ap5sjueetr7ga6bu54